2018
DOI: 10.1016/j.jmb.2018.06.052
|View full text |Cite
|
Sign up to set email alerts
|

DDX17 Specifically, and Independently of DDX5, Controls Use of the HIV A4/5 Splice Acceptor Cluster and Is Essential for Efficient Replication of HIV

Abstract: HIV splicing involves five splice donor and eight splice acceptor sequences which, together with cryptic splice sites, generate over 100 mRNA species. Ninety percent of both partially spliced and fully spliced transcripts utilize the intrinsically weak A4/A5 3′ splice site cluster. We show that DDX17, but not its close paralog DDX5, specifically controls the usage of this splice acceptor group. In its absence, production of the viral envelope protein and other regulatory and accessory proteins is grossly reduc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 72 publications
(93 reference statements)
2
9
0
Order By: Relevance
“…6), as previously reported 33 . Indeed, the RNA helicase activities of DDX5 and DDX17 have been implicated in resolving RNA structures, facilitating the recognition of the 5′ splice site (which can be embedded in secondary structures), and exposing RNA-binding motifs to additional splicing regulators 33,42,[48][49][50] . However, even though some RNA-binding specificity has been reported for DDX17 51,52 , these RNA helicases are devoid of a proper RNA-binding domain, and their activity in splicing likely depends on additional factors that are able to provide target specificity.…”
Section: Discussionmentioning
confidence: 99%
“…6), as previously reported 33 . Indeed, the RNA helicase activities of DDX5 and DDX17 have been implicated in resolving RNA structures, facilitating the recognition of the 5′ splice site (which can be embedded in secondary structures), and exposing RNA-binding motifs to additional splicing regulators 33,42,[48][49][50] . However, even though some RNA-binding specificity has been reported for DDX17 51,52 , these RNA helicases are devoid of a proper RNA-binding domain, and their activity in splicing likely depends on additional factors that are able to provide target specificity.…”
Section: Discussionmentioning
confidence: 99%
“…IBV [81] dsRNA sensing (with DDX21 and DHX36) [21] Transmissible gastroenteritis virus [18] NF-κB signaling [19] DDX3X Arenavirus [38] JEV [47] HIV [74,84] IFN-β induction (with TBK1) [26] Innate immune signaling [27,28] HBV [36,93] Myxoma virus [88] VACV K7 [34] HBV polymerase [35] HCV 3 UTR [37] DDX5 JEV [47] HIV [84] Myxoma virus [88] DDX6 Negative regulation of ISG induction [66] RVFV, LACV [40] IVB [65] Flaviviruses: sequestered by sfRNA [67,68] DDX10 HIV [89] DDX17 HIV [84,94] RVFV [41] Cofactor for ZAP [43] Tombusviruses [45] DDX18…”
Section: Ddx1mentioning
confidence: 99%
“…DDX17 and its close homolog DDX5 play an important role in various contexts, including processing of primary microRNA transcripts (pri-miRs) in the nucleus (Kao et al, 2019;Li et al, 2017;Mori et al, 2014), pre-mRNA alternative splicing Hö nig et al, 2002), ribosome biogenesis (Jalal et al, 2007), mRNA export (Montpetit et al, 2011), and coregulation of transcription Fuller-Pace, 2013a;Lambert et al, 2018;Samaan et al, 2014). DDX17 has also been implicated in immunity by affecting viral infectivity (Lorgeoux et al, 2013;Moy et al, 2014;Sithole et al, 2018). Dysregulated expression of DDX17 has been associated with many cancers, including those in colon, prostate, breast, brain, lung, stomach, and blood (Cai et al, 2017;Fuller-Pace and Moore, 2011).…”
Section: Introductionmentioning
confidence: 99%